David Y Liu Protagonist Therapeutics, Inc (PTGX) insider trading activity

PTGX Quotes by TradingView

David Y Liu is Chief R&D Strategy Officer of Protagonist Therapeutics, Inc. Currently has a direct ownership of 167,590 shares of PTGX, which is worth approximately $7.63 Million. The most recent transaction as insider was on Nov 16, 2022, when has been sold 100,479 shares (Common Stock) at a price of $2.0 per share, resulting in proceeds of $200,958. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 168K
0% 3M change
0% 12M change
Total Value Held $7.63 Million

David Y Liu Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 16 2022
BUY
Exercise of conversion of derivative security
$200,958 $2.0 p/Share
100,479 Added 37.48%
167,590 Common Stock
Feb 28 2022
SELL
Payment of exercise price or tax liability
$51,449 $24.28 p/Share
2,119 Reduced 3.09%
66,538 Common Stock
Feb 15 2022
BUY
Grant, award, or other acquisition
-
10,000 Added 12.71%
68,657 Common Stock
Aug 17 2021
SELL
Open market or private sale
$702,889 $47.56 p/Share
14,779 Reduced 20.24%
58,254 Common Stock
Aug 17 2021
BUY
Exercise of conversion of derivative security
$8,700 $0.87 p/Share
10,000 Added 12.04%
73,033 Common Stock
Feb 26 2021
BUY
Grant, award, or other acquisition
-
10,000 Added 13.81%
62,427 Common Stock
DYL

David Y Liu

Chief R&D Strategy Officer
Newark, CA

Track Institutional and Insider Activities on PTGX

Follow Protagonist Therapeutics, Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PTGX shares.

Notify only if

Insider Trading

Get notified when an Protagonist Therapeutics, Inc insider buys or sells PTGX shares.

Notify only if

News

Receive news related to Protagonist Therapeutics, Inc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PTGX